| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 55,257 | 48,309 | 38,243 | | Cost of Revenue | 13,225 | 10,137 | 7,626 | | | Gross Profit | 42,033 | 38,172 | 30,617 | | | Operating Expenses | | Research Development | 10,609 | 10,987 | 12,216 | | Selling General and Administrative | 42,422 | 39,753 | 33,170 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (10,998) | (12,568) | (14,769) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,138 | 1,528 | 1,260 | | Earnings Before Interest And Taxes | (9,860) | (11,040) | (13,509) | | Interest Expense | 364 | 213 | 209 | | Income Before Tax | (10,225) | (11,253) | (13,717) | | Income Tax Expense | (57) |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,167) | (11,253) | (13,717) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (10,167) | (11,253) | (13,717) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,167) | ($11,253) | ($13,717) |
|
0.29% Nasdaq 
Income Statement
